{
    "clinical_study": {
        "@rank": "158259", 
        "acronym": "CLOCK", 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess, in real life, the efficacy and the eligibility for\n      discharge of a local anesthetic, CLOROTEKAL\u00ae, used for spinal anesthesia in short outpatient\n      surgery."
        }, 
        "brief_title": "Impact of Chloroprocaine (CLOROTEKAL\u00ae) on Eligibility for Discharge From Hospital After Outpatient Surgery", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Spinal Anesthesia", 
            "Outpatient Surgery"
        ], 
        "detailed_description": {
            "textblock": "This is a longitudinal, observational, prospective, multicentre, national study, conducted\n      in France, from a representative sample of physician anesthetists.\n\n      The efficacy and safety in real life of CLOROTEKAL\u00ae will be assessed in patients undergoing\n      a short outpatient surgery under spinal anesthesia. Data will be collected by the physician\n      during two visits (pre-anesthesia and per-postoperative consultation). Additional data\n      regarding the patient's perception (safety, pain and satisfaction) will be collected using a\n      self-questionnaire."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients seen in pre-anesthesia consultation for ambulatory surgery\n\n          -  Patients for whom a spinal anesthesia using CLOROTEKAL\u00ae is planned\n\n          -  Patients accepting and able to complete a satisfaction self-administered\n             questionnaire\n\n          -  Informed patients who accept the computer processing of their medical data and\n             their right of access and correction\n\n        Exclusion Criteria:\n\n          -  Patients with contra-indications to spinal anesthesia (eg decompensated cardiac\n             insufficiency, hypovolemic shock\u2026.)\n\n          -  Patients with contra-indications to chloroprocaine (hypersensitivity to the active\n             substance, medicinal products of the para-aminobenzoic acid ester group, other\n             ester-type local anaesthetics or to any of the excipients ; Intravenous regional\n             anaesthesia (the anesthetic agent is introduced into the limb and allowed to set in\n             while tourniquets retain the agent within the desired area), serious problems with\n             cardiac conduction, severe anemia)\n\n          -  Patients participating or having participated in the previous month in a clinical\n             trial in anesthesiology"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients scheduled for surgery under spinal anesthesia of short duration will be informed\n        about the study and will be asked to participate, from about day -14 (pre-anesthesia\n        consultation) to 24h after the day of surgery."
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02152293", 
            "org_study_id": "CLOCK"
        }, 
        "intervention_browse": {
            "mesh_term": "Chloroprocaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 2, 2014", 
        "number_of_groups": "1", 
        "official_title": "Pharmacoepidemiology Study on Real Life Impact of Chloroprocaine (CLOROTEKAL\u00ae) on the Eligibility for Discharge From Hospital of Patients Requiring Short Outpatient Surgery Under Spinal Anesthesia", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Comit\u00e9 consultatif sur le traitement de l'information en mati\u00e8re de recherche dans le domaine de la sant\u00e9", 
                "France: Conseil National de l'Ordre des M\u00e9decins", 
                "France: French Data Protection Authority"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time to eligibility for discharge from hospital measured as the time between the intrathecal injection and achieving the criteria of Lacasse.\nThis period will be described globally (average time) and by groups: <180 min ; <240 min ; <300 min ; <360 min ; > 360 min.", 
            "measure": "Impact of CLOROTEKAL\u00ae on the discharge from hospital", 
            "safety_issue": "No", 
            "time_frame": "Average time expected around 180 min after the surgery (Lacasse, 2011)"
        }, 
        "reference": {
            "PMID": "21203878", 
            "citation": "Lacasse MA, Roy JD, Forget J, Vandenbroucke F, Seal RF, Beaulieu D, McCormack M, Massicotte L. Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trial. Can J Anaesth. 2011 Apr;58(4):384-91. doi: 10.1007/s12630-010-9450-x. Epub 2011 Jan 4."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02152293"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Modalities of spinal anesthesia with CLOROTEKAL\u00ae", 
                "safety_issue": "No", 
                "time_frame": "During surgery"
            }, 
            {
                "description": "Percentage and nature of adverse effect (serious or not) after intrathecal anaesthesia with chloroprocaine.", 
                "measure": "Safety of CLOROTEKAL", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 24 hours after surgery"
            }, 
            {
                "measure": "Patients' satisfaction", 
                "safety_issue": "No", 
                "time_frame": "24h after surgery"
            }, 
            {
                "measure": "Postoperative patients pain", 
                "safety_issue": "No", 
                "time_frame": "During the 24 hours following surgery"
            }, 
            {
                "measure": "Rate of unplanned admissions related to anesthesia and/or surgery", 
                "safety_issue": "No", 
                "time_frame": "Within the same day than surgery"
            }
        ], 
        "source": "GECEM", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GECEM", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}